Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06503588

Ureteral Stent Exchange Abstention in Urinary Tract Infections

The Committee of Infectiology of the French Association of Urology (CIAFU) provided, for the first time in 2020, comprehensive guidelines for ureteral stent-associated urinary tract infections (USAUTI) prevention, diagnosis and treatment. Since evidence lacked in terms of appropriate treatment, guidelines could not support systematic change of US in case of USAUTI.

This study aims to evaluate whether "after guidelines group" patients treated for USAUTI had different occurrence of at least one relapse or recurrence than "before guidelines group".

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Nancy university hospital

Nancy, Lorraine, 54000, France

Location status: Recruiting

Location contact

Benjamin Lefevre, MD PhD

CONTACT

[email protected]

+33383154097

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients with indwelling ureteral catheter
  • AND confirmed or probable urinary tract infection

Exclusion criteria

  • Patient's opposition
  • History of ileal conduit urinary diversion
  • Second or more urinary tract infection during the study period

Treatment and study plan

Guidelines promoting surgical abstention

Other

Guidelines promoting surgical abstention

Primary outcomes

  1. Relapse OR recurrence of urinary tract infection

    Time frame: 1 year

Secondary outcomes

  1. Nephro-urologic complication

    Time frame: 1 year

    Acute kidney injury ; hematuria ; pain ; stent migration or incrustation

  2. Infectious complication

    Time frame: 1 year

    Sepsis or septic shock

  3. In-hospital and 1-year mortality

    Time frame: 1 year

    all cause death

  4. Resort to Watch or Reserve antibiotics

    Time frame: 1 year

    antibiotics' WHO classifcation

Study contacts

Contact information is provided by the study sponsor or research team.

Benjamin Lefevre, M.D. PhD

CONTACT

[email protected]

+33383154097

Tahani Sara

CONTACT

[email protected]

+33383154097

Sponsors and collaborators

Lead sponsor

Central Hospital, Nancy, France

Other

Registry information

Official study title

Ureteral Stent Exchange Abstention in Urinary Tract Infections: a Before-and-after Study to Assess Guidelines' Impact on Patients' Outcomes

Acronym: JJ-change-UTI

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 16, 2024
Registry last updated
Aug 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.